Most Recent
A court has summarily dismissed a lawsuit accusing the Victorian government of acting unlawfully by improving the Western Highway and threatening to harm six 'directions' trees of cultural significance to the Djab Wurrung people.
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
McDonald’s Australia has been joined as a second respondent in a union-led lawsuit that accuses the fast food giant of “conspiring to deliberately deny workers their breaks”.
Supermarket chain Romeo's has reached a settlement in two class actions alleging staff were underpaid, but details of the agreements are scant.
A judge has directed that the legal fees and funding commission sought to be deducted from a $125 million class action settlement with Crown Resorts be included in a proposed notice to shareholders, after learning that group members were forced to click through to Maurice Blackburn's website to find the "critical" figures.
ASIC has won its bid to wind up accused Sydney fraudster Melissa Caddick's company and appoint final receivers to realise her assets, paving the way for some repayment to the dozens of family and friends who invested with Caddick and are still owed $23.5 million.
A class action on behalf of people who claim they developed non-Hodgkin lymphoma after using Monsanto's Roundup weed killer will argue the agrochemical giant should be hit with exemplary damages for its negligence in selling the herbicide, which the company allegedly knew caused cancer.
The Finance Sector Union has launched legal proceedings in the Fair Work Commission against the Commonwealth Bank for allegedly sacking an employee who breached a “draconian” salary secrecy clause.
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.
Embattled technology company Nuix has been hit with a shareholder class action over its $1.8 billion December float on the ASX.